Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Dec;72(6):1867–1873. doi: 10.1172/JCI111149

Biosynthesis and release of thyrotropin-releasing hormone immunoreactivity in rat pancreatic islets in organ culture. Effects of age, glucose, and streptozotocin.

L O Dolva, J H Nielsen, B S Welinder, K F Hanssen
PMCID: PMC437025  PMID: 6227632

Abstract

Thyrotropin-releasing hormone immunoreactivity (TRH-IR) was measured in isolated islets and in medium from rat pancreatic islets maintained in organ culture. TRH-IR in methanol extracts of both islets and culture medium was eluted in the same position as synthetic TRH by ion-exchange and gel chromatography and exhibited dilution curves parallel with synthetic TRH in radioimmunoassay. [3H]Histidine was incorporated into a component that reacted with TRH antiserum and had the same retention time as synthetic TRH on reversed-phase high-performance liquid chromatography. A continuous release of TRH-IR into the culture medium was observed from islets of both 5-d-old (newborn) and 30-d-old (adult) rats with a maximum on the second day of culture (28.7 +/- 7.0 and 13.3 +/- 3.6 fmol/islet per d, respectively). The content of TRH-IR was higher in freshly isolated islets from newborn rats (22.4 +/- 2.3 fmol/islet) than in adult rat islets, which, however, increased their content from 1.3 +/- 0.5 to 7.0 +/- 0.5 fmol/islet during the first 3 d of culture. Adult rat islets maintained in medium with 20 mM glucose released significantly more TRH-IR than islets in 3.3 mM glucose medium (13.0 +/- 0.7 vs. 4.3 +/- 0.3 fmol/islet per d). In contrast, the content of TRH-IR in the islets was reversed (1.4 +/- 0.3 vs. 4.7 +/- 1.6 fmol/islet). By exposing islets from newborn rats to streptozotocin 0.7 mg/ml for 30 min, a 50% reduction of TRH-IR content in the islets compared with the non-treated islets was seen after subsequent culture for 7 d. The insulin content was reduced by 80%, while glucagon was slightly elevated. In conclusion, these results indicate that TRH is synthesized in rat pancreatic islets, and that the release is stimulated by glucose.

Full text

PDF
1867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berelowitz M., Shapiro B., Pimstone B., Kronheim S. Growth hormone release inhibitory hormone-like immunoreactivity in pancreas and gut in streptozotocin diabetes in the rat and response to insulin administration. Clin Endocrinol (Oxf) 1979 Feb;10(2):195–198. doi: 10.1111/j.1365-2265.1979.tb01366.x. [DOI] [PubMed] [Google Scholar]
  2. Bone A. J., Swenne I., Hellerström C. Effects of high glucose concentrations on the insulin biosynthesis of rat pancreatic islets maintained for extended periods in tissue culture. Diabete Metab. 1981 Dec;7(4):259–263. [PubMed] [Google Scholar]
  3. Bradbury A. F., Finnie M. D., Smyth D. G. Mechanism of C-terminal amide formation by pituitary enzymes. Nature. 1982 Aug 12;298(5875):686–688. doi: 10.1038/298686a0. [DOI] [PubMed] [Google Scholar]
  4. Brunstedt J. Rapid isolation of functionally intact pancreatic islets from mice and rats by percollTM gradient centrifucation. Diabete Metab. 1980 Jun;6(2):87–89. [PubMed] [Google Scholar]
  5. Dolva L. O., Hanssen K. F., Aadland E., Sand T. Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man. J Clin Endocrinol Metab. 1983 Mar;56(3):524–529. doi: 10.1210/jcem-56-3-524. [DOI] [PubMed] [Google Scholar]
  6. Dolva L. O., Hanssen K. F., Flaten O., Hanssen L. E., von Schenck H. The effect of thyrotrophin-releasing hormone (TRH) on pancreatic hormone secretion in normal subjects. Acta Endocrinol (Copenh) 1983 Feb;102(2):224–230. doi: 10.1530/acta.0.1020224. [DOI] [PubMed] [Google Scholar]
  7. Engler D., Scanlon M. F., Jackson I. M. Thyrotropin-releasing hormone in the systemic circulation of the neonatal rat is derived from the pancreas and other extraneural tissues. J Clin Invest. 1981 Mar;67(3):800–808. doi: 10.1172/JCI110097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eskay R. L., Oliver C., Warberg J., Porter J. C. Inhibition of degradation and measurement of immunoreactive thyrotropin-releasing hormone in rat blood and plasma. Endocrinology. 1976 Feb;98(2):269–277. doi: 10.1210/endo-98-2-269. [DOI] [PubMed] [Google Scholar]
  9. Green I. C., Taylor K. W. Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J Endocrinol. 1972 Aug;54(2):317–325. doi: 10.1677/joe.0.0540317. [DOI] [PubMed] [Google Scholar]
  10. Halban P. A., Wollheim C. B. Intracellular degradation of insulin stores by rat pancreatic islets in vitro. An alternative pathway for homeostasis of pancreatic insulin content. J Biol Chem. 1980 Jul 10;255(13):6003–6006. [PubMed] [Google Scholar]
  11. Heding L. G. Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia. 1971 Feb;7(1):10–19. doi: 10.1007/BF02346248. [DOI] [PubMed] [Google Scholar]
  12. Junod A., Lambert A. E., Orci L., Pictet R., Gonet A. E., Renold A. E. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 1967 Oct;126(1):201–205. doi: 10.3181/00379727-126-32401. [DOI] [PubMed] [Google Scholar]
  13. Kawano H., Daikoku S., Saito S. Location of thyrotropin-releasing hormone-like immunoreactivity in rat pancreas. Endocrinology. 1983 Mar;112(3):951–955. doi: 10.1210/endo-112-3-951. [DOI] [PubMed] [Google Scholar]
  14. Kazumi T., Utsumi M., Hirose Y., Ishihara K., Makimura H., Ejiri K., Taniguchi H., Baba S. Protection by nicotinamide against streptozotocin-induced reduction in pancreatic TRH. Acta Endocrinol (Copenh) 1982 Dec;101(4):570–573. doi: 10.1530/acta.0.1010570. [DOI] [PubMed] [Google Scholar]
  15. Kazumi T., Utsumi M., Yoshino G., Ishihara K., Hirose Y., Makimura H., Baba S. Somatostatin concentration responds to arginine in portal plasma: effects of fasting, streptozotocin diabetes, and insulin administration in diabetic rats. Diabetes. 1980 Jan;29(1):71–73. doi: 10.2337/diab.29.1.71. [DOI] [PubMed] [Google Scholar]
  16. Koivusalo F. Evidence of thyrotropin-releasing hormone activity in autopsy pancreata from newborns. J Clin Endocrinol Metab. 1981 Oct;53(4):734–736. doi: 10.1210/jcem-53-4-734. [DOI] [PubMed] [Google Scholar]
  17. Koivusalo F., Leppäluoto J. High TRF immunoreactivity in purified pancreatic extracts of fetal and newborn rats. Life Sci. 1979 Apr 30;24(18):1655–1658. doi: 10.1016/0024-3205(79)90249-2. [DOI] [PubMed] [Google Scholar]
  18. Koivusalo F., Leppäluoto J., Knip M., Rajaniemi H. Presence of TRF immunoreactivity in marginal islet cells in rat pancreas. Acta Endocrinol (Copenh) 1981 Jul;97(3):398–404. doi: 10.1530/acta.0.0970398. [DOI] [PubMed] [Google Scholar]
  19. Leppäluoto J., Koivusalo F., Kraama R. Thyrotropin-releasing factor: distribution in neural and gastrointestinal tissues. Acta Physiol Scand. 1978 Oct;104(2):175–179. doi: 10.1111/j.1748-1716.1978.tb06264.x. [DOI] [PubMed] [Google Scholar]
  20. Leppäluoto J., Vuolteenaho O., Koivusalo F. Thyrotropin releasing factor: radioimmunoassay and distribution in biological fluids and tissues. Med Biol. 1981 Apr;59(2):85–91. [PubMed] [Google Scholar]
  21. Lernmark A. [Isolated mouse islets as a model for studying insulin release]. Acta Diabetol Lat. 1971 Jul-Aug;8(4):649–679. doi: 10.1007/BF01550894. [DOI] [PubMed] [Google Scholar]
  22. Martino E., Lernmark A., Seo H., Steiner D. F., Refetoff S. High concentration of thyrotropin-releasing hormone in pancreatic islets. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4265–4267. doi: 10.1073/pnas.75.9.4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Martino E., Seo H., Lernmark A., Refetoff S. Ontogenetic patterns of thyrotropin-releasing hormone-like material in rat hypothalamus, pancreas, and retina: selective effect of light deprivation. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4345–4348. doi: 10.1073/pnas.77.7.4345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Morley J. E., Garvin T. J., Pekary A. E., Hershman J. M. Thyrotropin-releasing hormone in the gastrointestinal tract. Biochem Biophys Res Commun. 1977 Nov 7;79(1):314–318. doi: 10.1016/0006-291x(77)90097-3. [DOI] [PubMed] [Google Scholar]
  25. Morley J. E., Levin S. R., Pehlevanian M., Adachi R., Pekary A. E., Hershman J. M. The effects of thyrotropin-releasing hormone on the endocrine pancreas. Endocrinology. 1979 Jan;104(1):137–139. doi: 10.1210/endo-104-1-137. [DOI] [PubMed] [Google Scholar]
  26. Nielsen J. H., Brunstedt J., Andersson A., Frimodt-Møller C. Preservation of beta cell function in adult human pancreatic islets for several months in vitro. Diabetologia. 1979 Feb;16(2):97–100. doi: 10.1007/BF01225457. [DOI] [PubMed] [Google Scholar]
  27. Nielsen J. H. Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets. Endocrinology. 1982 Feb;110(2):600–606. doi: 10.1210/endo-110-2-600. [DOI] [PubMed] [Google Scholar]
  28. Paquette T. L., Gingerich R., Scharp D. Altered amidation of pancreatic polypeptide in cultured dog islet tissue. Biochemistry. 1981 Dec 22;20(26):7403–7408. doi: 10.1021/bi00529a013. [DOI] [PubMed] [Google Scholar]
  29. Thim L., Moody A. J. The primary structure of porcine glicentin (proglucagon). Regul Pept. 1981 May;2(2):139–150. doi: 10.1016/0167-0115(81)90007-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES